The glucocorticoid sparing efficacy of PhytopicaTMin the management of canine atopic dermatitis
- 1 February 2010
- journal article
- research article
- Published by Wiley in Veterinary Dermatology
- Vol. 21 (1) , 97-105
Abstract
This double-blind randomized placebo-controlled trial indicates that Phytopica can be an effective glucocorticoid sparing agent in canine atopic dermatitis (AD). Twenty-two dogs with perennial AD [Canine Atopic Dermatitis with Severity Index (CADESI-03) >or= 60] were given 200 mg/kg Phytopica or an identical placebo in food once daily for 56 days. All dogs were initially given 0.4 mg/kg methyl-prednisolone once daily, which was then adjusted according to the daily pruritus score (0-100 mm visual analogue scale). The cumulative dose and pruritus score were lower in the Phytopica than the placebo group. There were statistically significant time and treatment effects for the methyl-prednisolone dose and pruritus score, but there were no significant differences between the Phytopica and placebo groups in the proportion of dogs that achieved a > 50% reduction in dose or pruritus scores at day 56; the mean CADESI-03 scores at days 0, 28 and 56; the numbers achieving >50% reduction in CADESI-03 at days 28 and 56; or in the owners' global efficacy score at days 28 and 56. Adverse events included diarrhoea (three Phytopica and one placebo treated dog), polyuria/polydipsia (three dogs in each group), and polyphagia, intermittent anorexia and panting (one dog each in the placebo group). None of these by themselves required withdrawal of treatment.Keywords
This publication has 32 references indexed in Scilit:
- Tepoxalin reduces pruritus and modified CADESI‐01 scores in dogs with atopic dermatitis: a prospective, randomized, double‐blinded, placebo‐controlled, cross‐over studyVeterinary Dermatology, 2009
- Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo‐controlled trialVeterinary Dermatology, 2009
- Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double‐blind, placebo‐controlled clinical studyVeterinary Dermatology, 2006
- P-76 The effect of omega-3 fatty acid supplementation on cutaneous and plasma fatty acid concentrations in dogs with atopic dermatitisVeterinary Dermatology, 2004
- A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitisVeterinary Dermatology, 2004
- Resveratrol derivatives potently induce apoptosis in human promyelocytic leukemia cellsExperimental & Molecular Medicine, 2003
- Skin Immune System and Allergic Skin Diseases2001
- An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tincturesPhytomedicine, 2000
- Iatrogenic hyperadrenocorticism in 28 dogsJournal of the American Animal Hospital Association, 1999
- Combined treatment with concentrated essential fatty acids and prednisolone in the management of canine atopy1994